Nabriva Therapeutics Plc
(OTC) NBRVF
Nabriva Therapeutics Plc Financials at a Glance
Market Cap
$600
Revenue (TTM)
$29.39M
Net Income (TTM)
$55.05M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-246.85 (Low)
Dividend
$0.00
Beta (Volatility)
-246.85 (Low)
Price
$0.00
Volume
10
Open
$0.00
Price
$0.00
Volume
10
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-246.85 (Low)
Price
$0.00
Volume
10
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
NBRVF News
NBRVF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nabriva Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
39
CEO
Theodore R. Schroeder
Website
www.nabriva.comHeadquarters
Dublin, 4, IE
NBRVF Financials
Key Financial Metrics (TTM)
Gross Margin
20%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-13%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$600.00
Shares Outstanding
3.23M
Volume
10
Short Interest
0.00%
Avg. Volume
297.25
Financials (TTM)
Gross Profit
$7.09M
Operating Income
$55.49M
EBITDA
$54.70M
Operating Cash Flow
$36.71M
Capital Expenditure
$211.00K
Free Cash Flow
$36.92M
Cash & ST Invst.
$12.41M
Total Debt
$5.22M
Nabriva Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.57M
-70.7%
Gross Profit
$6.50M
-250.4%
Gross Margin
-2.53%
N/A
Market Cap
$600.00
N/A
Market Cap/Employee
$15.38
N/A
Employees
39
N/A
Net Income
$12.06M
-8.9%
EBITDA
$12.01M
-16.3%
Quarterly Fundamentals
Net Cash
$1.64M
-87.3%
Accounts Receivable
$4.44M
-64.1%
Inventory
$0.00
-100.0%
Long Term Debt
$344.00K
-32.8%
Short Term Debt
$196.00K
-97.0%
Return on Assets
-1.80%
N/A
Return on Invested Capital
-13.34%
N/A
Free Cash Flow
$511.00K
+103.9%
Operating Cash Flow
$511.00K
+103.9%